Solventum Corp | SOLV - Equity Capital And Reserves


Solventum Corp reported $4.8B in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
Abbott USD 52.06B 69M Mar/2026
Align Technology USD 4.23B 83.03M Jun/2026
Baxter International USD 6.21B 163M Jun/2026
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Cencora USD 3.4B 1.49B Mar/2026
Dexcom USD 2.62B 335.5M Jun/2026
Insulet USD 1.42B 119.6M Jun/2026
Solventum Corp USD 4.8B 169M Jun/2026
West Pharmaceutical Services USD 2.99B 200K Jun/2026
Zimmer Biomet Holdings USD 12.63B 49.1M Jun/2026